Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A rare primary lymphedema characterized by extensive, multisegmental lymphedema, associated with persistent, widespread infections with various genital high- and low-risk human papillomaviruses, resulting in multifocal anogenital dysplasia. Laboratory examination shows abnormalities in lymphocyte subsets, in particular CD4+ T-cells. Epidermal nevi and capillary malformations have also been reported.
Biomarker and diagnostic research for warts-immunodeficiency-lymphedema-anogenital dysplasia syndrome has been reported in the published literature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for warts-immunodeficiency-lymphedema-anogenital dysplasia syndrome.
202 publications have been identified in PubMed for warts-immunodeficiency-lymphedema-anogenital dysplasia syndrome. Kisho has analyzed 56 by research type. Research spans Review / Meta-Analysis (75%), Basic Science / Preclinical (11%), and Epidemiology / Natural History (7%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 42 | 75% |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 6:41 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
Laboratory research | 6 | 11% |
Disease patterns and progression | 4 | 7% |
Testing and diagnosis research | 2 | 4% |
Patient case studies | 1 | 2% |
Clinical study results | 1 | 2% |
Creignou M (2026). [PMID: 41651099](https://pubmed.ncbi.nlm.nih.gov/41651099/). *Semin Cancer Biol*. [Review / Meta-Analysis]
Tafti D (2026). [PMID: 30422542](https://pubmed.ncbi.nlm.nih.gov/30422542/). *Unknown Journal*. [Basic Science / Preclinical]
Tsatsopoulou A (2026). [PMID: 40316016](https://pubmed.ncbi.nlm.nih.gov/40316016/). *Hellenic J Cardiol*. [Review / Meta-Analysis]
Pfirrmann C (2026). [PMID: 40998114](https://pubmed.ncbi.nlm.nih.gov/40998114/). *Orthop Traumatol Surg Res*. [Review / Meta-Analysis]
Vignes S (2025). [PMID: 40640921](https://pubmed.ncbi.nlm.nih.gov/40640921/). *Orphanet J Rare Dis*. [Review / Meta-Analysis]
Littman JL (2025). [PMID: 41300813](https://pubmed.ncbi.nlm.nih.gov/41300813/). *Genes (Basel)*. [Review / Meta-Analysis]
Nicolae R (2025). [PMID: 40658013](https://pubmed.ncbi.nlm.nih.gov/40658013/). *Curr Opin Pediatr*. [Review / Meta-Analysis]
Carraway HE (2025). [PMID: 41348013](https://pubmed.ncbi.nlm.nih.gov/41348013/). *Hematology Am Soc Hematol Educ Program*. [Review / Meta-Analysis]
Pazelli AM (2025). [PMID: 40848647](https://pubmed.ncbi.nlm.nih.gov/40848647/). *J Plast Reconstr Aesthet Surg*. [Epidemiology / Natural History]
Thalambedu N (2025). [PMID: 39941875](https://pubmed.ncbi.nlm.nih.gov/39941875/). *Cancers (Basel)*. [Review / Meta-Analysis]